Xofluza (baloxavir marboxil) met its primary endpoint in the CENTERSTONE trial, reducing the odds of untreated household ...

EditForce, Inc. (Headquarters: Fukuoka, Japan) is pleased to announce that a research paper on the results of a joint study with the research group led by Professor Masayuki Nakamori of the Department ...

The Canadian Cancer Society (CCS) closed the 32nd edition of its prestigious Montreal Daffodil Ball by raising a historic amount of $3,413,908. Presented under the theme Prospective, the Ball ...

Detailed results from the CENTERSTONE trial show treatment with Xofluza reduced the odds of transmission, or spread of the ...

One dose of the antiviral baloxavir marboxil lowers the chance of transmitting the influenza virus to family members by about ...

One dose of the antiviral baloxavir marboxil lowers the chance of transmitting the influenza virus to family members by about ...

A middle school student north of Dallas has tested positive. Meanwhile, Illinois has confirmed its first case in the state. Plus: A study in mice shows that covid is still contagious a week or more ...

A landmark study published in The New England Journal of Medicine [link to the publication] reveals that a single oral dose of baloxavir marboxil ...

A single dose of the antiviral baloxavir marboxil (Xofluza) led to a lower incidence of influenza virus transmission to ...

2024年公司继续推进多个创新药项目，如Pixavir Marboxil胶囊已提交上市申请，多个项目进入临床阶段。公司坚持创新驱动发展战略，通过自主研发 ...

Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, ...